Editorial Material
2025
·
0 citations
Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Patient With Larynx Carcinoma
Abstract
Significance Statement Posterior reversible encephalopathy syndrome (PRES) is characterized by variable neurological findings such as headache, deterioration in mental condition, loss of consciousness and visual loss. The disease results with impairment of the cerebral blood flow autoregulation. Ondansetron, serotonin (5HT-3) receptor antagonist, may cause the haemorrhagic PRES.
Keywords
haemorrhagic posterior reversible encephalopathy syndrome
ondensatron
magnetic resonance imaging
susceptibility weighted imaging
SPECTRUM
WoS Categories
Otorhinolaryngology
Sustainable Development Goals
Citation
- Journal
- ENT-EAR NOSE & THROAT JOURNAL
- Year
- 2025
- Volume
- 104
- Issue
- 10
- Pages
- NP649-NP650
- ISSN
- 0145-5613
- eISSN
- 1942-7522
- DOI
- 10.1177/01455613221150121
- WoS UID
- WOS:000906850300001